Search Within

Karlo Perica

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Hematology-Oncology Fellows (8)
  5. Sloan Kettering Institute Postdocs (8)
  6. Hematologic Malignancies Research (6)

More Groups

People
  1. Michel Sadelain (5)
  2. Anton Dobrin (3)
  3. Jae Park (3)
  4. Nayan Jain (3)
  5. Audrey Mauguen (2)
  6. Christopher Forlenza (2)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2021 (1)
Publications
  1. Blood (1)
  2. Human Gene Therapy (1)
  3. Molecular Therapy (1)
  4. Nature (1)
  5. Nature Cancer (1)
  6. New England Journal of Medicine (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. Mary Ann Liebert, Inc (1)
  5. Massachusetts Medical Society (1)
  6. Nature Research (1)

More Publishers

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HIV immune evasin Nef enhances allogeneic CAR T cell potency
    Journal Article

    Perica, K.; Kotchetkov, I. S.; Mansilla-Soto, J.; Ehrich, F.; Herrera, K.; Shi, Y.; Dobrin, A.; Gönen, M.; Sadelain, M.
    Nature (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
    Journal Article

    Dobrin, A.; Lindenbergh, P. L.; Shi, Y.; Perica, K.; Xie, H.; Jain, N.; Chow, A.; Wolchok, J. D.; Merghoub, T.; Sadelain, M.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Allogeneic CAR T cells with regulated NEF expression display immune evasion and optimized signaling
    Meeting Abstract

    Perica, K.; Mansilla-Soto, J.; Kotchetkov, I.; Sadelain, M.
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia
    Journal Article

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save